Functional distinction in oncogenic Ras variant activity in Caenorhabditis elegans

Area of Science:

• Oncology
• Molecular Biology
• Developmental Biology

Background:

• Ras genes are key oncogenes frequently mutated in human cancers.
• Distinct oncogenic Ras variants have varied effects on cancer types, cellular targets, and drug sensitivity.
• Understanding how these variants interact with cellular networks is crucial but poorly understood.

Purpose of the Study:

• To identify novel components in the interplay between Ras genotype and cellular interaction networks in vivo.
• To investigate the functional distinctions of specific Ras oncogenic substitution changes.
• To explore how different Ras variants respond to genetic modulators and extracellular signals.

Main Methods:

• Development and application of a vulva-development assay in the nematode C. elegans as an experimental framework.
• Evaluation of Ras oncogenic substitution changes at G12, G13, and Q61.
• Analysis of phenotypic differences, sensitivity to gene dosage, and MEK inhibition.

Main Results:

• Ras oncogenic variants were categorized into distinct groups based on observed phenotypic differences.
• Variant responses varied concerning gene dosage sensitivity and inhibition of the downstream kinase MEK.
• Genetic modulators influencing Ras activity non-autonomously demonstrated variant-restricted effects in vivo.

Conclusions:

• Oncogenic Ras variants in C. elegans display distinct mechanisms of interaction with the vulva-development network.
• Extracellular modulators exert variant-specific effects on Ras activity and downstream pathways in vivo.
• This study provides a framework for dissecting Ras variant functions in a complex biological network.